Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Baclofen 💬1件: Baclofen1件: Baclofen2件: GABBR,
GABBR 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬7件: 2, 10, 13, 18, 65, 149, 206 💬
2 Botulinum toxin type A 💬1件: Botulinum toxin type A5件: Botulinum toxin A; Botulinum toxin type A; BTX-A; Incobotulinumtoxina; Onabotulinumtoxina1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬13件: 2, 5, 6, 7, 13, 15, 17, 47, 51, 113, 149, 171, 226 💬
3 Brivaracetam 💬1件: Brivaracetam1件: Brivaracetam1件: SV2 💬 1件: ECM-receptor interaction 💬2件: 149, 309 💬
4 Charcoal, activated 💬1件: Activated charcoal2件: Activated charcoal; Carbon--6件: 6, 13, 85, 97, 149, 235 💬
5 Ezetimibe 💬1件: Ezetimibe1件: Ezetimibe1件: NPC1L1 💬 1件: Fat digestion and absorption 💬4件: 79, 93, 149, 260 💬
6 Fenfluramine 💬1件: Fenfluramine2件: Fenfluramine; Fenfluramine hydrochloride5件: HTR1,
HTR2,
HTR2,
SIGMAR1,
SLC6A4 💬 		11件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬4件: 140, 144, 145, 149 💬
7 Fenfluramine hydrochloride 💬1件: Fenfluramine2件: Fenfluramine; Fenfluramine hydrochloride5件: HTR1,
HTR2,
HTR2,
SIGMAR1,
SLC6A4 💬 		11件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬4件: 140, 144, 145, 149 💬
8 Lacosamide 💬1件: Lacosamide1件: Lacosamide2件: SCN3A,
SCN9A 💬 		1件: Taste transduction 💬4件: 2, 46, 149, 298 💬
9 Levetiracetam 💬1件: Levetiracetam1件: Levetiracetam1件: SV2 💬 1件: ECM-receptor interaction 💬7件: 2, 4, 6, 13, 34, 149, 307 💬
10 Melatonin 💬1件: Melatonin1件: Melatonin2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬16件: 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202 💬
11 Oxygen 💬1件: Oxygen1件: Oxygen--13件: 22, 49, 70, 85, 86, 88, 149, 168, 235, 271, 298, 299, 330 💬
12 Padsevonil 💬1件: Padsevonil1件: Padsevonil3件: SV2,
SV2,
SV2 💬 		1件: ECM-receptor interaction 💬1件: 149 💬
13 Prabotulinumtoxin A 💬1件: Botulinum toxin type A5件: Botulinum toxin A; Botulinum toxin type A; BTX-A; Incobotulinumtoxina; Onabotulinumtoxina1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬13件: 2, 5, 6, 7, 13, 15, 17, 47, 51, 113, 149, 171, 226 💬
14 Sodium oxybate 💬1件: Sodium oxybate1件: Sodium oxybate--2件: 6, 149 💬
15 Tocilizumab 💬1件: Tocilizumab1件: Tocilizumab1件: IL6R 💬 11件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬24件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬
16 Triheptanoin 💬1件: Triheptanoin1件: Triheptanoin--10件: 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 💬